A detailed history of Princeton Capital Management LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Princeton Capital Management LLC holds 13,757 shares of LLY stock, worth $11.1 Million. This represents 3.94% of its overall portfolio holdings.

Number of Shares
13,757
Previous 14,034 1.97%
Holding current value
$11.1 Million
Previous $8.18 Million 30.83%
% of portfolio
3.94%
Previous 3.35%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$592.2 - $792.28 $164,039 - $219,461
-277 Reduced 1.97%
13,757 $10.7 Million
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $96,109 - $113,300
183 Added 1.32%
14,034 $8.18 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $1.53 Million - $2.11 Million
3,520 Added 34.07%
13,851 $7.44 Million
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $19,641 - $26,262
-56 Reduced 0.54%
10,331 $4.85 Million
Q1 2023

May 01, 2023

SELL
$310.63 - $364.82 $231,108 - $271,426
-744 Reduced 6.68%
10,387 $3.57 Million
Q4 2022

Jan 31, 2023

SELL
$321.55 - $374.67 $198,396 - $231,171
-617 Reduced 5.25%
11,131 $4.07 Million
Q3 2022

Nov 10, 2022

BUY
$296.48 - $337.87 $530,402 - $604,449
1,789 Added 17.96%
11,748 $3.8 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $1.88 Million - $2.21 Million
6,743 Added 209.67%
9,959 $3.23 Million
Q1 2022

May 11, 2022

BUY
$234.69 - $291.66 $18,540 - $23,041
79 Added 2.52%
3,216 $921,000
Q4 2021

Feb 09, 2022

BUY
$224.85 - $279.04 $5,396 - $6,696
24 Added 0.77%
3,137 $867,000
Q3 2021

Nov 10, 2021

BUY
$221.6 - $272.71 $11,966 - $14,726
54 Added 1.77%
3,113 $719,000
Q2 2021

Aug 11, 2021

BUY
$180.55 - $233.54 $83,053 - $107,428
460 Added 17.7%
3,059 $702,000
Q1 2021

May 12, 2021

BUY
$164.32 - $212.72 $79,530 - $102,956
484 Added 22.88%
2,599 $486,000
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $11,551 - $13,361
-79 Reduced 3.6%
2,115 $313,000
Q2 2020

Aug 10, 2020

BUY
$136.42 - $164.18 $72,166 - $86,851
529 Added 31.77%
2,194 $360,000
Q1 2020

May 13, 2020

BUY
$119.05 - $147.35 $27,143 - $33,595
228 Added 15.87%
1,665 $261,000
Q4 2019

Feb 12, 2020

BUY
$106.92 - $132.43 $39,560 - $48,999
370 Added 34.68%
1,437 $210,000
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $1,922 - $2,090
-18 Reduced 1.66%
1,067 $119,000
Q1 2018

May 03, 2018

BUY
$74.21 - $87.6 $80,517 - $95,046
1,085 New
1,085 $84,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $765B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Princeton Capital Management LLC Portfolio

Follow Princeton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Princeton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Princeton Capital Management LLC with notifications on news.